Given the pathological relevance of tau, particularly its phosphorylated forms, this protein has become a key biomarker for AD diagnosis in body fluids, highlighting the potential contribution of peripheral ptau species to disease progression [38,39]. The gene discussed is MAPT; the disease is Alzheimer disease.